Polymer-conjugated glucosamine complexed with boric acid shows tumor-selective accumulation and simultaneous inhibition of glycolysis
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Polymer-conjugated glucosamine complexed with boric acid shows tumor-selective accumulation and simultaneous inhibition of glycolysis
Authors
Keywords
Tumor selective, Glycolysis inhibition, Multifunctional, Mild-hypoxia, Treatment of advanced tumor, BNCT
Journal
BIOMATERIALS
Volume 269, Issue -, Pages 120631
Publisher
Elsevier BV
Online
2020-12-26
DOI
10.1016/j.biomaterials.2020.120631
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The entry of nanoparticles into solid tumours
- (2020) Shrey Sindhwani et al. NATURE MATERIALS
- Poly(vinyl alcohol) boosting therapeutic potential of p-boronophenylalanine in neutron capture therapy by modulating metabolism
- (2020) Takahiro Nomoto et al. Science Advances
- Exploiting the dynamics of the EPR effect and strategies to improve the therapeutic effects of nanomedicines by using EPR effect enhancers
- (2020) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- Spatiotemporally Targeted Nanomedicine Overcomes Hypoxia-Induced Drug Resistance of Tumor Cells after Disrupting Neovasculature
- (2020) Jinjin Chen et al. NANO LETTERS
- Investigating the EPR effect of nanomedicines in human renal tumors via ex vivo perfusion strategy
- (2020) Yuxun Ding et al. Nano Today
- Thrombin Generation and Cancer: Contributors and Consequences
- (2019) Caroline Reddel et al. Cancers
- Glucosamine inhibits IL-1β expression by preserving mitochondrial integrity and disrupting assembly of the NLRP3 inflammasome
- (2019) Hsiao-Wen Chiu et al. Scientific Reports
- Augmentation of EPR Effect and Efficacy of Anticancer Nanomedicine by Carbon Monoxide Generating Agents
- (2019) Jun Fang et al. Pharmaceutics
- Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases
- (2019) Helen Strongman et al. LANCET
- Engineered nanomedicines with enhanced tumor penetration
- (2019) Jianxun Ding et al. Nano Today
- Perspectives on the past, present, and future of cancer nanomedicine
- (2018) Yu Seok Youn et al. ADVANCED DRUG DELIVERY REVIEWS
- HPMA copolymer conjugate with pirarubicin: In vitro and ex vivo stability and drug release study
- (2018) Waliul Islam et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Augmentation of the Enhanced Permeability and Retention Effect with Nitric Oxide-Generating Agents Improves the Therapeutic Effects of Nanomedicines
- (2018) Waliul Islam et al. MOLECULAR CANCER THERAPEUTICS
- Arterial thromboembolic events preceding the diagnosis of cancer in older persons
- (2018) Babak B. Navi et al. BLOOD
- Block copolymer-boron cluster conjugate for effective boron neutron capture therapy of solid tumors
- (2017) Peng Mi et al. JOURNAL OF CONTROLLED RELEASE
- Sildenafil citrate improves the delivery and anticancer activity of doxorubicin formulations in a mouse model of breast cancer
- (2017) Khaled Greish et al. JOURNAL OF DRUG TARGETING
- Strategies for Preparing Albumin-based Nanoparticles for Multifunctional Bioimaging and Drug Delivery
- (2017) Fei-Fei An et al. Theranostics
- Use of boron cluster-containing redox nanoparticles with ROS scavenging ability in boron neutron capture therapy to achieve high therapeutic efficiency and low adverse effects
- (2016) Zhenyu Gao et al. BIOMATERIALS
- pH-sensitive polymeric cisplatin-ion complex with styrene-maleic acid copolymer exhibits tumor-selective drug delivery and antitumor activity as a result of the enhanced permeability and retention effect
- (2016) Atsuyuki Saisyo et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Albumin nanostructures as advanced drug delivery systems
- (2016) Mahdi Karimi et al. Expert Opinion on Drug Delivery
- A Retrospective 30 Years After Discovery of the Enhanced Permeability and Retention Effect of Solid Tumors: Next-Generation Chemotherapeutics and Photodynamic Therapy-Problems, Solutions, and Prospects
- (2016) Hiroshi Maeda et al. MICROCIRCULATION
- Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity
- (2015) Hiroshi Maeda ADVANCED DRUG DELIVERY REVIEWS
- HPMA Copolymer-Conjugated Pirarubicin in Multimodal Treatment of a Patient with Stage IV Prostate Cancer and Extensive Lung and Bone Metastases
- (2015) Haruhiko Dozono et al. Targeted Oncology
- Anti-cancer activity of glucosamine through inhibition of N-linked glycosylation
- (2014) Viktor Chesnokov et al. Cancer Cell International
- EPR: Evidence and fallacy
- (2014) Joseph W. Nichols et al. JOURNAL OF CONTROLLED RELEASE
- Styrene-maleic acid copolymer-encapsulated CORM2, a water-soluble carbon monoxide (CO) donor with a constant CO-releasing property, exhibits therapeutic potential for inflammatory bowel disease
- (2014) Hongzhuan Yin et al. JOURNAL OF CONTROLLED RELEASE
- Therapeutic efficacy of boron neutron capture therapy mediated by boron-rich liposomes for oral cancer in the hamster cheek pouch model
- (2014) Elisa M. Heber et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The link between infection and cancer: Tumor vasculature, free radicals, and drug delivery to tumors via the EPR effect
- (2013) Hiroshi Maeda CANCER SCIENCE
- Questions on the role of the EPR effect in tumor targeting
- (2013) Kinam Park JOURNAL OF CONTROLLED RELEASE
- Biodistribution and bioimaging studies of hybrid paclitaxel nanocrystals: Lessons learned of the EPR effect and image-guided drug delivery
- (2013) Christin P. Hollis et al. JOURNAL OF CONTROLLED RELEASE
- Two step mechanisms of tumor selective delivery of N-(2-hydroxypropyl)methacrylamide copolymer conjugated with pirarubicin via an acid-cleavable linkage
- (2013) Hideaki Nakamura et al. JOURNAL OF CONTROLLED RELEASE
- The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
- (2012) Hiroshi Maeda et al. ADVANCED DRUG DELIVERY REVIEWS
- Doxil® — The first FDA-approved nano-drug: Lessons learned
- (2012) Yechezkel (Chezy) Barenholz JOURNAL OF CONTROLLED RELEASE
- Macromolecular therapeutics in cancer treatment: The EPR effect and beyond
- (2012) Hiroshi Maeda JOURNAL OF CONTROLLED RELEASE
- Thrombosis and cancer
- (2012) Annie Young et al. Nature Reviews Clinical Oncology
- Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting
- (2012) Hiroshi MAEDA PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Intracellular uptake and behavior of two types zinc protoporphyrin (ZnPP) micelles, SMA-ZnPP and PEG-ZnPP as anticancer agents; unique intracellular disintegration of SMA micelles
- (2011) Hideaki Nakamura et al. JOURNAL OF CONTROLLED RELEASE
- Enhanced delivery of macromolecular antitumor drugs to tumors by nitroglycerin application
- (2009) Takahiro Seki et al. CANCER SCIENCE
- Glucosamine-induced endoplasmic reticulum stress attenuates apolipoprotein B100 synthesis via PERK signaling
- (2009) Wei Qiu et al. JOURNAL OF LIPID RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started